Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-905-90
Published July 9, 2025 · Recall initiated: June 26, 2025
Summary
FDA records drug Class III recall D-0528-2025, published July 9, 2025 and initiated June 26, 2025. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 1,560 bottles; Lot: Lot, expiry: Lot 46208, exp 10/31/2025; Lot 47738, exp 09/30/2026; Lot 46943, exp 05/31/2026. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurity/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if PITAVASTATIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PITAVASTATIN
- Manufacturer
- AvKARE
- Distributor
- Nationwide in the USA
- Lot
- Lot, expiry: Lot 46208, exp 10/31/2025; Lot 47738, exp 09/30/2026; Lot 46943, exp 05/31/2026;
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPitavastatin Tablets, 1 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road,July 9, 2025
- FDAPitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC:July 9, 2025
- FDAPitavastatin Tablets, 2 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road,July 9, 2025
- FDACefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use, Rx Only,July 9, 2025
- FDAMetoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01;July 9, 2025
- FDABuffered Penicillin G Potassium for Injection, USP 20,000,000 Units (20 million units), For IV use, Sterile,July 9, 2025
Questions about this recall
Was Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-905-90 recalled?
Yes. FDA published recall D-0528-2025 on July 9, 2025. Reported hazard: Failed Impurity/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PITAVASTATIN.